Jun 21, 2023

Featuring perspectives from Dr Lyudmila A Bazhenova, Ms Kelly EH Goodwin, Dr Virginia Kaklamani, Ms Caroline Kuhlman, Ms Alexis N McKinney and Dr Zev Wainberg, including the following topics:

• Introduction (0:00)
• HER2 as a Therapeutic Target; Antibody-Drug Conjugates (6:15)
• HER2-Positive Breast Cancer (23:08)

Feb 28, 2023

Featuring a slide presentation and related discussion from Dr Mrinal Gounder, including the following topics:

•      Efficacy and tolerability of sorafenib in patients with advanced and refractory desmoid tumors (00:00)

•      DESMOPAZ: Results of a Phase II trial of pazopanib versus IV methotrexate/vinblastine...

Feb 28, 2023

Featuring perspectives from Dr Mrinal Gounder, including the following topics:

•      Incidence and prevalence of desmoid tumors (00:00)

•      Outcomes associated with historical management paradigms for desmoid tumors (17:15)

•      Rationale for targeting the gamma secretase complex and Notch pathway as...

Feb 15, 2023

Featuring perspectives from Drs Jonathan Strosberg and Lori Wirth, including the following topics:

• Nontargeted Treatment for Thyroid Cancer   
  • Introduction (0:00)
  • Case: A woman in her late 60s with poorly differentiated thyroid cancer initially treated with lenvatinib – Dr Wirth (6:05)
• NTRK Fusions in Thyroid...

Nov 1, 2022

Featuring a slide presentation and related discussion from Dr Pamela Kunz, including the following topics:

• Epidemiology of neuroendocrine tumors (NETs) (0:00)
• Strategies for the hormonal control of NETs (11:03)
• Tools for tumor control (17:03)

CME information and select...